Op-Eds
Flu pandemic prevention
This month's outbreak of H5N1 avian flu in Turkey—as many as 50 human cases and several deaths—looks very like what we might see…
Op-Eds
Ominous Prospects for Aging
A recent article in the Wall Street Journal described “a growing backlash against the pharmaceutical industry that is already affecting the development and…
Op-Eds
CEOs Should Mind Their Own Business
President Coolidge once said the business of America is business. He might have added that the business of business is to pursue profits,…
Op-Eds
Good Drugs, Bad Rap
These are turbulent times for the pharmaceutical industry and for its regulator, the FDA. Lately, both have focused increasingly on issues of safety.
Op-Eds
The Long REACH of the EU
The European Union's Council of Ministers is expected to vote soon on the proposed chemicals regulation called REACH, an acronym for Registration, Evaluation, and…
Op-Eds
The UN’s War Against Innovation
The leadership of the United Nations is truly the gang that can't shoot straight. Even if the recent incidents of corruption and profiteering—exemplified…